Study suggests how to build a better ‘nanopore’
biosensor

27th April 2021by admin0

Researchers have spent more than three decades
developing and studying miniature biosensors that can identify
single molecules. In 5 to 10 years, when such devices may become a
staple in doctors’ offices, they could detect molecular markers for
cancer and other diseases and assess the effectiveness of drug
treatment to fight those illnesses.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright ©2024 New Fusion All Rights Reserved

      Designed by FallingBrick